Back to search results

Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Abroad (travel likely)RecruitingPHASE2

Conditions

Metastatic Castration-resistant Prostate Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Tumorzentrum Aarau TZA, Aarau, Switzerland

    Contact: Study coordinator (Konstantinos Tyriakidis, MD) · konstantinos.tyriakidis@tumor-zentrum.ch · +41 62 836 78 30
    Contact: Principal Investigator (Konstantinos Tyriakidis, MD)

  • Kantonsspital Baden, Baden, Switzerland

    Contact: Study coordinator (Andreas Erdmann, MD) · andreas.erdmann@ksb.ch · +41 56 486 27 62
    Contact: Principal Investigator (Andreas Erdmann, MD)

  • Istituto Oncologico della Svizzera Italiana (IOSI), Bellinzona, Switzerland

    Contact: Study coordinator (Ursula Vogl, MD) · ursula.vogl@eoc.ch · +41 91 811 84 63
    Contact: Principal Investigator (Ursula Vogl, MD)

  • Inselspital, Bern, Switzerland

    Contact: Study coordinator (Dilara Akhoundova, MD) · dilara.akhoundovasanoyan@insel.ch · +41 31 63 2 03 91
    Contact: Principal Investigator (Dilara Akhoundova Dilara Akhoundova, MD)

  • Kantonsspital Graubuenden, Chur, Switzerland

    Contact: Study coordinator (Richard Cathomas, MD) · richard.cathomas@ksgr.ch · 41-81-256-6695
    Contact: Principal Investigator (Richard Cathomas, MD)

  • Hôpitaux Universitaires Genève HUG, Geneva, Switzerland

    Contact: Study coordinator (Petros Tsantoulis, MD) · petros.tsantoulis@hcuge.ch · +41 79 553 23 53
    Contact: Principal Investigator (Petros Tsantoulis, MD)

  • Centre Hospitalier Universitaire Vaudois CHUV, Lausanne, Switzerland

    Contact: Study coordinator (Dominik Berthold, MD) · dominik.berthold@chuv.ch · +41 21 314 80 83
    Contact: Principal Investigator (Dominik Berthold, MD)

  • Luzerner Kantonsspital, Lucerne, Switzerland

    Contact: Study coordinator (Christian Rothermundt, MD) · christian.rothermundt@luks.ch · +41 41 205 58 60
    Contact: Principal Investigator (Christian Rothermundt, MD)

  • Kantonsspital St. Gallen, Sankt Gallen, Switzerland

    Contact: Study coordinator (Stefanie Fischer, MD) · stefanie.fischer@kssg.ch · +41 71 494 11 11
    Contact: Principal Investigator (Stefanie Fischer, MD)

  • Kantonsspital Winterthur, Winterthur, Switzerland

    Contact: Study coordinator (Gina Treichler, MD) · gina.treichler@ksw.ch · +41 52 266 38 53
    Contact: Principal Investigator (Gina Treichler, MD)

  • OnkoZentrum Zürich - Standort Seefeld, Zurich, Switzerland

  • Stadtspital Triemli Zürich, Zurich, Switzerland

    Contact: Study coordinator (Katharina Hoppe, MD) · katharina.hoppe@stadtspital.ch · +41 44 416 34 91
    Contact: Principal Investigator (Katharina Hoppe, MD)

  • UniversitaetsSpital Zuerich, Zurich, Switzerland

    Contact: Study coordinator (Anja Lorch, Prof) · anja.lorch@usz.ch · +41 44 255 22 14
    Contact: Principal Investigator (Anja Lorch, Prof)
Study leads

  • Richard Cathomas, Prof

    Study Chair

    Kantonsspital Graubünden

  • Ursula Vogl, MD

    Study Chair

    Istituto Oncologico della Svizzera Italiana

View source on ClinicalTrials.gov(opens in a new tab)